Core Laboratories (CLB) Cost of Revenue (2022 - 2026)

Core Laboratories has reported Cost of Revenue for 5 years, with the latest figure at $26.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 2.0% year-over-year to $26.0 million; the trailing twelve-month figure through Mar 2026 stood at $346.6 million (up 70.53% YoY), and the FY2025 full-year result was $302.2 million, up 1.64% from the prior year.
• Cost of Revenue for Q1 2026 stood at $26.0 million, down from $216.1 million in the prior quarter.
• The five-year high for Cost of Revenue was $216.1 million in Q4 2025, with the low at -$85.3 million in Q4 2022.
• Historically, Cost of Revenue has averaged $42.1 million across 5 years, with a median of $30.1 million in 2022.
• The largest YoY upside for Cost of Revenue was 195.44% in 2025 against a maximum downside of 13.78% in 2025.
• Core Laboratories' Cost of Revenue stood at -$85.3 million in 2022, then soared by 135.66% to $30.4 million in 2023, then surged by 140.47% to $73.1 million in 2024, then surged by 195.44% to $216.1 million in 2025, then sank by 87.99% to $26.0 million in 2026.
• The last three Cost of Revenue figures came in at $26.0 million (Q1 2026), $216.1 million (Q4 2025), and $74.9 million (Q3 2025), per Business Quant data.